Twist Bioscience's Series E - II Round

Twist Bioscience raised a round of funding on May 18, 2017.

Twist Bioscience is a biotechnology company offering synthetic DNA production for specialty chemical compounds and drug development. By synthesizing DNA on silicon instead of on traditional 96-well pl…

Articles about Twist Bioscience's Series E - II Round: